View drug registration information details.
Items | Registration information |
ID | 51 |
No | 51 |
Brand Name | MINOPHAGEN C |
Ingredients | MONOAMMONIUM GLYCYRRHIZINATE 53 MG (AS GLYCYRRHIZIC ACID 40 MG), GLYCINE JP 400 MG, L-CYSTEINE HYDROCHLORIDE HYDRATE 22.29 MG (L-CYSTEINE HYDROCHLORIDE 20 MG) |
Dosage Form | SOLUTION FOR INJECTION |
Primary Packaging | AMPOULES |
Storage | |
Shelf Life | 36 MONTHS |
Pack Size | 20 ML/AMPOULES, BOX OF 30 AMPOULES |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | ECZEMA OR DERMATITIS, URTICARIA, PRURITUS, DRUG ERUPTION OR TOXICODERMA, STOMATITIS, INFANT STROPHULUS, PHLYCTEN. IMPROVEMENT OF ABNORMAL HEPATIC FUNCTION IN CHRONIC LIVER DISEASES. |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | COLORLESS, CLEAR AQUEOUS INJECTION IN GLASS AMPOULES |
Note | |
License Owner | AI KEN PHARMA CO., LTD |
Manufacturer | MINOPHAGEN PHARMACEUTICAL CO.,LTD., ZAMA FACTORY |
Country | JAPAN |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 02 I 5204/22 |
FDD Registration Date | 16-DEC-2024 |
Expiry Date | 15-DEC-2029 |
Back to drug list
|